SAF-189s

SAF-189s · Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SAF-189s, covering 2021-07-08 to 2024-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Study Of Comparing SAF-189s With Crizotinib In First Line ALK-Positive Advanced and Metastatic NSCLC [Phase 3]